Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2023 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Mpox vaccine and infection-driven human immune signatures: an immunological analysis of an observational study.
Cohn H, Bloom N, Cai GY, Clark JJ, Tarke A, Bermúdez-González MC, Altman DR, Lugo LA, Lobo FP, Marquez S; PVI study group; Chen JQ, Ren W, Qin L, Yates JL, Hunt DT, Lee WT, Crotty S, Krammer F, Grifoni A, Sette A, Simon V, Coelho CH. Cohn H, et al. Lancet Infect Dis. 2023 Nov;23(11):1302-1312. doi: 10.1016/S1473-3099(23)00352-3. Epub 2023 Jul 17. Lancet Infect Dis. 2023. PMID: 37475115 Free PMC article.
Mapping of human monoclonal antibody responses to XBB.1.5 COVID-19 monovalent vaccines: a B cell analysis.
Fantin RF, Clark JJ, Cohn H, Jaiswal D, Bozarth B, Rao V, Civljak A, Lobo I, Nardulli JR, Srivastava K, Yong JS, Andreata-Santos R, Bushfield K, Lee ES, Singh G; PVI Study Group; Kleinstein SH, Krammer F, Simon V, Bajic G, Coelho CH. Fantin RF, et al. Lancet Microbe. 2025 May 30:101103. doi: 10.1016/j.lanmic.2025.101103. Online ahead of print. Lancet Microbe. 2025. PMID: 40456237 Free article.
XBB.1.5 monovalent vaccine induces lasting cross-reactive responses to SARS-CoV-2 variants such as HV.1 and JN.1, as well as SARS-CoV-1, but elicits limited XBB.1.5 specific antibodies.
Carreño JM, Lerman B, Singh G, Abbad A, Yellin T, Ehrenhaus J, Fried M, Nardulli JR, Kang HM, Mulder LCF, Gleason C, Srivastava K; PVI study group; Simon V, Krammer F. Carreño JM, et al. mBio. 2025 Apr 9;16(4):e0360724. doi: 10.1128/mbio.03607-24. Epub 2025 Mar 5. mBio. 2025. PMID: 40042313 Free PMC article.